Your browser is no longer supported. Please, upgrade your browser.
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-7.63 Insider Own1.00% Shs Outstand34.35M Perf Week0.29%
Market Cap471.34M Forward P/E35.51 EPS next Y0.39 Insider Trans-92.72% Shs Float33.71M Perf Month51.22%
Income-259.50M PEG- EPS next Q-0.01 Inst Own- Short Float30.09% Perf Quarter38.22%
Sales297.00M P/S1.59 EPS this Y-178.40% Inst Trans-0.25% Short Ratio6.98 Perf Half Y58.03%
Book/sh7.26 P/B1.88 EPS next Y160.30% ROA-32.20% Target Price11.96 Perf Year15.16%
Cash/sh4.27 P/C3.20 EPS next 5Y- ROE-81.50% 52W Range4.41 - 13.80 Perf YTD12.33%
Dividend- P/FCF- EPS past 5Y-35.40% ROI-80.00% 52W High-0.94% Beta1.14
Dividend %- Quick Ratio1.40 Sales past 5Y21.40% Gross Margin64.00% 52W Low209.98% ATR0.36
Employees440 Current Ratio1.60 Sales Q/Q-32.40% Oper. Margin-79.70% RSI (14)72.64 Volatility0.37% 2.19%
OptionableYes Debt/Eq0.00 EPS Q/Q89.20% Profit Margin-87.40% Rel Volume0.49 Prev Close13.66
ShortableYes LT Debt/Eq1.14 EarningsAug 06 BMO Payout- Avg Volume1.45M Price13.67
Recom3.00 SMA208.34% SMA5024.08% SMA20052.78% Volume713,047 Change0.07%
Aug-18-20Downgrade Barclays Overweight → Equal Weight $10
Oct-30-19Downgrade Piper Jaffray Neutral → Underweight $9 → $6
Aug-01-19Initiated H.C. Wainwright Buy $16
Jun-11-19Initiated Barclays Overweight $19
Mar-20-19Initiated SunTrust Hold
Dec-14-18Reiterated B. Riley FBR Buy $29 → $20.50
Nov-06-18Downgrade JP Morgan Neutral → Underweight
Jun-15-18Downgrade Janney Buy → Neutral
May-21-18Resumed Leerink Partners Mkt Perform
Mar-14-18Reiterated B. Riley FBR, Inc. Neutral $16 → $23
Feb-15-18Upgrade Janney Neutral → Buy
Dec-07-17Initiated B. Riley FBR, Inc. Neutral $16
Oct-23-17Initiated Piper Jaffray Neutral $18
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Oct-21-20 10:20PM  
09:01PM  
11:49AM  
10:10AM  
Oct-20-20 06:13PM  
Oct-17-20 02:05PM  
Oct-15-20 03:42PM  
12:24PM  
07:30AM  
07:30AM  
Oct-14-20 09:16PM  
06:52PM  
04:11PM  
Oct-12-20 08:00AM  
Oct-09-20 05:44PM  
02:24PM  
Oct-08-20 01:47PM  
Oct-07-20 06:30PM  
01:45PM  
11:25AM  
Oct-06-20 06:50PM  
Oct-05-20 10:30PM  
09:05PM  
11:04AM  
10:30AM  
Oct-02-20 08:35PM  
08:01PM  
06:50PM  
05:55PM  
03:45PM  
03:45PM  
01:02PM  
02:33AM  
Oct-01-20 06:49PM  
02:12PM  
01:13PM  
11:32AM  
11:23AM  
09:25AM  
Sep-09-20 08:00AM  
Sep-05-20 11:31AM  
Aug-12-20 12:00PM  
Aug-07-20 10:45AM  
Aug-06-20 09:55AM  
07:00AM  
Jul-30-20 12:33PM  
Jul-28-20 08:00AM  
Jul-27-20 07:30AM  
Jul-23-20 07:13AM  
Jul-21-20 06:15AM  
Jul-12-20 08:30AM  
Jul-06-20 10:00AM  
Jun-11-20 01:55PM  
07:00AM  
Jun-10-20 11:30AM  
May-27-20 08:00AM  
May-21-20 05:00PM  
May-12-20 12:26PM  
May-11-20 12:00PM  
09:45AM  
07:32AM  
07:00AM  
May-06-20 06:51AM  
May-05-20 06:13AM  
Apr-28-20 12:33PM  
07:00AM  
Apr-27-20 04:30PM  
Apr-16-20 08:00AM  
Apr-03-20 11:30AM  
Apr-02-20 01:23PM  
Mar-25-20 12:00PM  
Mar-13-20 03:59AM  
Mar-09-20 09:49AM  
Mar-05-20 08:21AM  
Mar-04-20 08:35AM  
07:00AM  
06:58AM  
Mar-01-20 08:31AM  
Feb-28-20 08:00AM  
Feb-26-20 08:46AM  
Feb-19-20 08:53AM  
Feb-14-20 04:34PM  
08:00AM  
Feb-10-20 05:40PM  
Feb-03-20 03:05PM  
Jan-30-20 12:31PM  
Jan-27-20 02:45PM  
09:00AM  
Jan-24-20 06:12PM  
Jan-21-20 06:15PM  
Jan-14-20 11:05PM  
12:00PM  
Jan-10-20 06:08PM  
09:59AM  
Jan-09-20 05:43PM  
10:21AM  
09:55AM  
07:00AM  
Jan-03-20 08:00AM  
Dec-18-19 08:00AM  
AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, and anemia management in the United States. The company markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women. Its product candidates also include AMAG-423 (ovine), an antibody fragment, which is in Phase 2b/3a trial for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent that is in planned Phase 2b trial for the treatment of novel oral anticoagulants or low molecular weight heparin. The company sells Feraheme to authorized wholesalers and specialty distributors. The company has license agreements with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio, LLC, Prasco, LLC, Perosphere Pharmaceuticals Inc., and Antares Pharma, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Camber Capital Management LP10% OwnerOct 01Sale13.574,390,00059,586,7870Oct 05 11:21 AM
ARMISTICE CAPITAL, LLC10% OwnerMar 16Buy4.8724,000116,880348,000Mar 18 04:52 PM
ARMISTICE CAPITAL, LLC10% OwnerFeb 25Buy8.2936,000298,440324,000Feb 27 05:27 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 27Buy9.418,00075,280288,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 27Buy9.438,00075,4404,120,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 24Buy9.7240,000388,800280,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 24Buy9.5834,000325,7204,112,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 10Buy11.6418,000209,5204,078,000Jan 13 05:47 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 09Buy12.3312,466153,7064,060,000Jan 13 05:47 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 09Sale12.4312,466154,9524,047,534Jan 13 05:47 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.